Zacks Research Upgrades Lifeward (NASDAQ:LFWD) to Hold

Lifeward (NASDAQ:LFWD) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $10.00.

Lifeward Price Performance

Lifeward stock opened at $6.99 on Monday. The company has a quick ratio of 1.82, a current ratio of 2.40 and a debt-to-equity ratio of 1.16. Lifeward has a 52-week low of $4.14 and a 52-week high of $10.56. The firm has a market cap of $19.63 million, a PE ratio of -0.36 and a beta of 0.37. The company’s 50 day moving average is $7.39 and its two-hundred day moving average is $7.05.

Lifeward (NASDAQ:LFWD) last posted its quarterly earnings results on Friday, May 15th. The company reported ($6.70) EPS for the quarter, missing the consensus estimate of ($1.18) by ($5.52). The business had revenue of $3.92 million during the quarter, compared to analyst estimates of $5.78 million. Lifeward had a negative return on equity of 243.14% and a negative net margin of 123.66%. On average, research analysts expect that Lifeward will post -4.27 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in LFWD. Virtu Financial LLC lifted its position in shares of Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after acquiring an additional 37,037 shares during the period. Jane Street Group LLC increased its stake in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after purchasing an additional 29,927 shares in the last quarter. HRT Financial LP raised its holdings in Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after purchasing an additional 29,423 shares during the last quarter. Finally, Citadel Advisors LLC boosted its position in Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares in the last quarter. 26.76% of the stock is owned by hedge funds and other institutional investors.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.